Biogen Inc. buy BMO Capital Markets
Start price
14.02.24
/
50%
€206.60
Target price
14.02.25
€265.53
Performance (%)
-35.26%
End price
15.02.25
€133.75
Summary
This prediction ended on 15.02.25 with a price of €133.75. The BUY prediction by BMO_Capital_Markets for Biogen Inc. performed very badly with a performance of -35.26%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.015% | -2.015% | 4.219% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $295.00 to $285.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten